Aggressive Fibromatosis clinical trials at UC Health
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This study evaluates nirogacestat in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). Half of the participants will receive nirogacestat while the other half will receive placebo.
at UCLA UCSF